DHH-B
$88.00
DHH-B (Dehydrohydroxybenzoquinone-B) is a synthetic derivative of a naturally occurring benzoquinone compound known for its neuro-regenerative and nootropic potential. It is under investigation for its role in nerve repair, mood regulation, and cognitive enhancement. DHH-B interacts with key signaling pathways that influence brain plasticity, neuroprotection, and inflammation control. Research on DHH-B is growing rapidly, particularly in areas involving neuroinflammation, neurogenesis, and stress response. You can buy DHH-B online from reputable suppliers for research and educational use.
Key Benefits
Neuroregenerative Support – Promotes nerve repair and may support recovery after injury or neurological trauma.
Cognitive Enhancement – May help improve memory, focus, and brain performance under stress.
Mood and Stress Regulation – Supports the modulation of neurotransmitter activity involved in mood balance.
Anti-Inflammatory Action – May reduce neuroinflammation associated with brain fog, fatigue, or age-related decline.
Mitochondrial Health – Has shown potential to support cellular energy systems in brain cells.
Mechanism of Action
- DHH-B is believed to influence BDNF (brain-derived neurotrophic factor) pathways, which are crucial for neuroplasticity and brain cell survival.
- It may also modulate oxidative stress and neuroinflammation by interacting with mitochondrial signaling and inflammatory cytokines.
- The peptide’s structure is designed to cross the blood-brain barrier, targeting brain tissue directly for enhanced cognitive support.
Dosage Recommendations
- Typical Dosage – Common research dosages range between 10–30 mg per day depending on study goals.
- Administration – Most commonly studied in capsule or oral formulation due to its bioavailability and CNS activity.
- Cycling – Often used in 4–8 week cycles with breaks in between to assess neurocognitive improvements.
Research and Studies
- Preclinical studies indicate potential benefits in models of traumatic brain injury, neuroinflammation, and degenerative cognitive decline.
- DHH-B has been linked to improvements in working memory and executive function in stress-related cognitive impairment.
- Additional research is underway to assess its synergy with other neuropeptides and mitochondrial enhancers.
Possible Side Effects and Contraindications
- Common Side Effects – Mild headache, fatigue, or vivid dreams may occur during early stages of use.
- Precautions – Not recommended for individuals with bipolar disorder or seizure history without medical oversight.
- Drug Interactions – May interact with other nootropics or mood-altering substances; avoid combining without professional guidance.
Storage and Handling Instructions
- Store capsules in a cool, dry place away from direct sunlight.
- Keep the container sealed tightly to maintain potency.
- Do not refrigerate unless instructed on the product label.
Frequently Asked Questions (FAQs)
- Is DHH-B a nootropic?
Yes, it is under investigation for its cognitive-enhancing and neuroprotective properties.
- How long until effects are noticed?
Some users report improved mental clarity within 1–2 weeks of consistent use.
- Can it be stacked with other peptides?
It may be paired with Dihexa or Semax in research settings for enhanced neuroprotective synergy.
Medical Disclaimer
DHH-B is intended for research and educational purposes only. It is not approved for human consumption or to diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any research protocol.
Related products
